INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 133 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $10,608 | +31.1% | 20,800 | 0.0% | 0.00% | – |
| Q3 2023 | $8,091 | -12.9% | 20,800 | 0.0% | 0.00% | – |
| Q2 2023 | $9,287 | -45.5% | 20,800 | 0.0% | 0.00% | – |
| Q1 2023 | $17,056 | -47.4% | 20,800 | 0.0% | 0.00% | – |
| Q4 2022 | $32,448 | -7.3% | 20,800 | 0.0% | 0.00% | – |
| Q3 2022 | $35,000 | 0.0% | 20,800 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -52.7% | 20,800 | 0.0% | 0.00% | – |
| Q1 2022 | $74,000 | -28.2% | 20,800 | 0.0% | 0.00% | – |
| Q4 2021 | $103,000 | -30.4% | 20,800 | 0.0% | 0.00% | – |
| Q3 2021 | $148,000 | -47.5% | 20,800 | -31.7% | 0.00% | – |
| Q2 2021 | $282,000 | 0.0% | 30,461 | 0.0% | 0.00% | – |
| Q1 2021 | $282,000 | +44.6% | 30,461 | +37.9% | 0.00% | – |
| Q4 2020 | $195,000 | -46.9% | 22,091 | -30.4% | 0.00% | -100.0% |
| Q3 2020 | $367,000 | +41.2% | 31,752 | +228.7% | 0.00% | 0.0% |
| Q2 2020 | $260,000 | +233.3% | 9,661 | -48.7% | 0.00% | – |
| Q4 2017 | $78,000 | -34.5% | 18,835 | 0.0% | 0.00% | – |
| Q3 2017 | $119,000 | -74.7% | 18,835 | -68.6% | 0.00% | -100.0% |
| Q2 2017 | $471,000 | -8.4% | 60,027 | -22.8% | 0.00% | 0.0% |
| Q1 2017 | $514,000 | -8.1% | 77,709 | -3.7% | 0.00% | 0.0% |
| Q4 2016 | $559,000 | – | 80,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|